Principal Display Panel -10 mg Bottle Label (43353 170)
Memantine Hydrochloride
Product Images NDC 43353-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 43353-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Chemical Structure (Memantine 01)
Figure 1 (Memantine 02)
Figure 2 (Memantine 03)
Figure 3 (Memantine 04)
Figure 4 (Memantine 05)
The given text is a graph showing the cumulative percentage of patients against the SIB (Severe Impairment Battery) change from baseline for two different treatments, placebo and memantine. The graph has 10 intervals with values not clearly visible.*
Figure 5 (Memantine 06)
The text describes a clinical study that measures changes in the ADCS-ADL score over time. The study assesses clinical improvement by analyzing the mean change in the score from baseline, but also evaluates clinical decline. The results are measured over a period of 8 weeks of treatment.*
Figure 6 (Memantine 07)
The text is a graph showing the cumulative percentage of patients on Placebo/Donepezil and Memantine/Donepezil, with ADCS-ADL change from Baseline to indicate the effectiveness of the drugs.*
Figure 7 (Memantine 08)
Figure 8 (Memantine 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
